图文详情
Abeprazan hydrochloride is a potassium-competitive acid blocker. It inhibits H+, K+- ATPase by reversible potassium-competitive ionic binding with no acid activation required. It is developed as a potential alternative to a proton pump inhibitor for the treatment of acid-related diseases.